About AllergoPharma
AllergoPharma is a company based in Reinbek (Germany) founded in 1969 was acquired by Dermapharm in February 2020. The company has 5,990 employees as of December 31, 2019. AllergoPharma operates in a competitive market with competitors including BeiGene, Vir Biotechnology, Cidara Therapeutics, BioNTech and Stallergenes Greer, among others.
- Headquarter Reinbek, Germany
- Employees 5990 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Allergopharma India Private Limited
- Date of Incorporation 02 Feb, 2024
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
5990
as on Dec 31, 2019
-
Acquired by
Dermapharm
(Feb 19, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AllergoPharma
Detailed funding history for AllergoPharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AllergoPharma
AllergoPharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dermapharm.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dermatological and pharmaceutical medications are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for AllergoPharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AllergoPharma
Investment portfolio details for AllergoPharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AllergoPharma
Detailed financials for AllergoPharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Allergopharma Comparisons
Peer comparison for AllergoPharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AllergoPharma
AllergoPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Vir Biotechnology, Cidara Therapeutics, BioNTech and Stallergenes Greer, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Allergen immunotherapies for respiratory allergies are developed.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
Detailed competitors of AllergoPharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Allergopharma
Complete news archive for AllergoPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AllergoPharma
AllergoPharma was founded in 1969.
AllergoPharma is headquartered in Reinbek, Germany. It is registered at Reinbek, Schleswig-holstein, Germany.
As of Dec 31, 2019, the latest employee count at AllergoPharma is 5,990.
AllergoPharma was founded in 1969 in Reinbek, Germany, as a specialty pharmaceutical company focused on allergen immunotherapies. As a subsidiary of Merck, causal treatments for IgE-mediated allergic diseases are developed, including subcutaneous options for unavoidable allergens such as pollen and dust mites. Operations center on advancing therapies for respiratory and other allergies in the European market.
AllergoPharma's top competitors include BeiGene, BioNTech and Decibel Therapeutics.
AllergoPharma has 1 investor. Key investors include Dermapharm.